Aptose Biosciences Inc.
APTODelisted Jul 21, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000882361
Aptose Biosciences Inc. was delisted on Jul 21, 2025; its insiders filed their last Form 4 on Jul 2, 2026; 16 institutions reported holding it in 13F filings for Q1 2025, worth $486.8K in total; no superinvestor held it.
Q2 2024 vs. Q1 2024
How the institutions holding Aptose Biosciences Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 27 | 24 | −3 |
| Shares | 1.01M | 2.71M | +1.70M (+167.6%) |
| Value | $1.68M | $2.06M | +$373.2K (+22.2%) |
New holders (2)
Institutions that held Aptose Biosciences Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 1,713,000 | $1.30M | 0.03% |
| ORG Partners LLC | 4,000 | $2.98K | 0.00% |
Sold out (5)
Institutions that held Aptose Biosciences Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Annandale Capital, LLC | 26,666 | $44.0K |
| Citadel Advisors LLC | 25,691 | $42.6K |
| Beaird Harris Wealth Management, LLC | 250 | $415 |
| Wells Fargo & Company | 72 | $120 |
| Bank of America Corp | 66 | $110 |